A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies

Area of Science:

• Pharmaceutical Chemistry
• Regulatory Science
• Toxicology

Background:

• The International Council for Harmonisation (ICH) M7 guideline addresses the control of mutagenic impurities in pharmaceuticals.
• Option 4 of ICH M7 permits the control of potentially mutagenic impurities based on scientific principles, bypassing routine analytical testing.
• Implementing Option 4 requires a robust scientific justification to ensure patient safety.

Purpose of the Study:

• To introduce a consortium-led initiative for implementing ICH M7 Option 4.
• To propose a framework for the supporting evidence required in regulatory submissions for this approach.
• To facilitate the adoption of scientifically-based impurity control strategies.

Main Methods:

• Review of ICH M7 guideline principles for impurity control.
• Development of a consortium-led strategy for data generation and submission.
• Proposal of evidence requirements, including theoretical and analytical data.

Main Results:

• A proposed framework for regulatory submissions under ICH M7 Option 4.
• Identification of key scientific principles and data types to support the approach.
• A pathway to reduce analytical testing burdens while maintaining safety standards.

Conclusions:

• ICH M7 Option 4 offers a scientifically sound alternative to routine testing for mutagenic impurities.
• A consortium-led initiative can provide the necessary support and guidance for its implementation.
• Well-supported scientific principles can effectively manage impurity risks and streamline regulatory processes.